Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?

Anna Čechová, Tomáš Honzík, Andrew C. Edmondson, Can Ficicioglu, Mercedes Serrano, Rita Barone, Pascale De Lonlay, Manuel Schiff, Peter Witters, Christina Lam, Marc Patterson, Mirian C.H. Janssen, Joana Correia, Dulce Quelhas, Jolanta Sykut-Cegielska, Horacio Plotkin, Eva Morava, Kyriakie Sarafoglou

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds